ReShape Lifesciences Inc.
RSLS
Get informed when a big investor buys or sells
+ FollowMarket Cap$15.48M
Close$
Share Statistics
| Market cap | $15.48 Million |
|---|---|
| Enterprise Value | $7.62 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.75 |
| Beta | 1.9 |
| Outstanding Shares | 7,018,528 |
Return
| Return on Equity | -161.66% |
|---|---|
| Return on Assets | -106.56% |
| Return on Invested Capital | -134.48% |
Valuation & Multiples
| P/E Ratio | -0.07 |
|---|---|
| PEG | 0.1 |
| Price to Sales | -3.92 |
| Price to Book Ratio | 3.92 |
| Enterprise Value to Revenue | -3.86 |
| Enterprise Value to EBIT | -0.78 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 18, 2025
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Vyome Holdings, Inc.
18 employees
CEO: Venkateswarlu Nelabhotla Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disor...